1352834-55-9

Basic information

• Product Name: (4-(5-chlorobenzo[d]oxazol-2-yl)-7-Methyl-1,4-diazepan-1-yl)(5-Methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)Methanone
• Synonyms: (4-(5-chlorobenzo[d]oxazol-2-yl)-7-Methyl-1,4-diazepan-1-yl)(5-Methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)Methanone
• CAS NO: 1352834-55-9
• Molecular Formula: C₂₃H₂₃ClN₆O₂
• Molecular Weight: 450.92072
• Mol File: 1352834-55-9.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 669.8±65.0 °C(Predicted)
• Appearance: /
• Density: 1.41±0.1 g/cm3(Predicted)
• PKA: 1.47±0.40(Predicted)
• CAS DataBase Reference: (4-(5-chlorobenzo[d]oxazol-2-yl)-7-Methyl-1,4-diazepan-1-yl)(5-Methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)Methanone(CAS DataBase Reference)
• NIST Chemistry Reference: (4-(5-chlorobenzo[d]oxazol-2-yl)-7-Methyl-1,4-diazepan-1-yl)(5-Methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)Methanone(1352834-55-9)
• EPA Substance Registry System: (4-(5-chlorobenzo[d]oxazol-2-yl)-7-Methyl-1,4-diazepan-1-yl)(5-Methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)Methanone(1352834-55-9)

Safety Data

• Hazardous Substances Data: 1352834-55-9(Hazardous Substances Data)

Usage

Description

(4-(5-chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone is a complex organic compound that features a benzoxazole moiety, a diazepane ring, a triazole ring, and a ketone functional group. This molecule is recognized for its potential as a pharmaceutical agent, exhibiting a range of biological activities including antimicrobial, antifungal, and antitumor properties. Its unique structural composition and the combination of these functional groups render it a promising candidate for drug development and therapeutic applications in various medical conditions.

Uses

Used in Pharmaceutical Development:
(4-(5-chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone is utilized as a potential pharmaceutical agent for its diverse biological activities. (4-(5-chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone's antimicrobial, antifungal, and antitumor properties make it a valuable asset in the development of new drugs to combat various diseases and infections.
Used in Antimicrobial Applications:
In the field of antimicrobials, (4-(5-chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone serves as an active ingredient to combat a range of microbial infections. Its ability to target and eliminate harmful microorganisms positions it as a potential solution for treating bacterial and fungal infections.
Used in Antifungal Treatments:
As an antifungal agent, (4-(5-chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone is applied to treat fungal infections. Its effectiveness against fungi makes it a candidate for developing treatments for conditions caused by fungal pathogens.
Used in Antitumor Research:
In oncology, (4-(5-chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone is explored for its antitumor properties. (4-(5-chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone's potential to inhibit tumor growth and its possible synergistic effects with existing cancer therapies make it a subject of interest for cancer treatment research.
Used in Medicinal Chemistry:
(4-(5-chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone is also used in the field of medicinal chemistry for further study and exploration. Its unique structure and functional groups offer opportunities for the design and synthesis of new compounds with improved pharmacological properties and therapeutic potential.

Upstream product

• 2941-78-8 2-Amino-5-methylbenzoic acid 
• 956317-36-5 2-(2H-1,2,3-triazol-2-yl)-5-methylbenzoic acid 
• 1030377-23-1 benzyl (2-((tert-butoxycarbonyl)amino)ethyl)(3-oxobutanoyl)carbamate 
• 1030377-24-2 1-benzyl 4-tert-butyl 5-methyl-1,4-diazepane-1,4-dicarboxylate 
• 1352834-53-7 (rac)-benzyl 5-methyl-1,4-diazepane-1-carboxylate hydrochloride 
• 1352834-54-8 benzyl 5-methyl-4-(5-methyl-2-(2H-1,2,3-triazole-2-yl)benzoyl)-1,4-diazepane-1-carboxylate 
• 1001401-59-7 (7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone 
• 17200-29-2 5-chloro-benzoxazole 
• 52548-14-8 2-iodoyl-5-methylbenzoic acid 
• 95-85-2 2-hydroxy-5-chloro-aniline 
• 90673-37-3 7-methyl-1,4-diazepan-5-one 
• 1104546-96-4 5-methyl-2-(2Η-1,2,3-triazol-2-yl)benzoyl chloride 
• 3621-81-6 2,5-dichloro-1,3-benzoxazole 
• 22876-19-3 5-chloro-2-mercaptobenzoxazole 

Relevant articles and documents

PROCESS FOR THE RESOLUTION OF (R,S)-DIAZEPANE AND DIAZEPANONE DERIVATIVES

The present invention relates to a process for the preparation of an acid salt (T) of a compound of formula (A) (A) as well as to the acid salt (T) and the compound (A) as such,wherein R1 is selected from the group consisting of H, PG1 and RA, with RA being or and wherein PG1 is a suitable protecting group, and wherein n is 0 or 1, wherein the acid salt (T) is the salt of one stereoisomer of a chiral acid, preferably wherein the chiral acid salt is a tartaric acid derivative salt, preferably wherein the tartaric acid derivative salt is selected from the group consisting of 2,3-ditoluoyl tartaric acid salt, 2,3-dibenzoyl tartaric acid salt, 2,3-dianisoyl tartaric acid salt, 2,3-dibenzoyl tartaric acid mono(dimethylamide) salt and a mixture of two or more thereof. Further the present invention relates to use of (T) and/or (A) for the preparation of suvorexant.